PLS Group shares (ASX: PLS) are stuttering into the final quarter of the year, after putting up one of the worst monthly performances among major ASX 200 stocks in September.
Heading into the last trading session of Q3 2026, PLS shares have fallen 28.33% in September alone, dragging the stock to around A$3.84 and cementing the quarter as the worst of the calendar year at -22.91%. The decline accelerated after the stock broke decisively below its 200-day SMA of A$5.00 roughly two weeks ago, with shares falling a further 22.75% from that technical breach.
The RSI has since dropped to 28.46, a level that places PLS firmly in oversold territory, yet the September drawdown does not exist in isolation. After a remarkable Q4 2025 that saw shares surge 67.46%, followed by a further 21.33% gain in Q1 2026, PLS reached an intraday high of A$6.81 in mid-June before the momentum reversed.
Q2 2026 closed fractionally lower at -1.95%, and Q3 has since wiped out a substantial portion of those prior gains. Despite the carnage of recent months, the stock still sits approximately 59.92% higher on a trailing twelve-month basis, a reminder of just how powerful the preceding rally was. Year-to-date in 2026, however, the picture is less flattering, with shares down 10.21% as the calendar year approaches its final stretch.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Driving The Pullback In PLS
The September selloff has taken place against a backdrop of falling lithium spot prices, with benchmark spodumene concentrate prices falling roughly 29% from their mid-May highs. That macro headwind has drawn significant short-selling interest, with short positions in PLS climbing to 11.2% of total issued capital, placing the stock among the ten most shorted names on the entire ASX 200.
What makes the technical and sentiment-driven selling particularly striking is that it has come on the heels of a genuinely strong set of full-year numbers. PLS Group delivered record FY26 results in late August, reporting revenue of A$1.93 billion, a 152% increase year-on-year, alongside a net profit after tax of A$525.8 million. That represents a dramatic reversal from the A$195.8 million loss recorded in FY25. Underlying EBITDA came in at A$1.14 billion, representing a 59% margin, while annual spodumene concentrate production reached a record 880,000 tonnes. FOB unit operating costs fell 9% to A$569 per tonne, reinforcing PLS Group’s position as one of the lowest-cost hard-rock lithium producers globally.
Management also resumed dividend payments after a two-year suspension, declaring a final fully-franked dividend of 5 cents per share, representing a total payout of approximately A$161 million.
Looking ahead, FY27 production guidance targets output of between 1.03 million and 1.10 million tonnes of spodumene concentrate, a midpoint increase of roughly 21% year-on-year as the Ngungaju processing plant ramps toward its full capacity of approximately 200,000 tonnes annually. Unit cost guidance for FY27 has been set slightly higher at A$575 to A$625 per tonne, reflecting plant integration costs associated with the ramp-up.
Capex is also stepping up materially, with FY27 guidance of A$630 million to A$685 million, including A$175 million in pre-Final Investment Decision spending on the major P2000 expansion project at Pilgangoora.
What Comes Next?
Looking to the analyst community for clues, and Ord Minnett has just upgraded its rating to Buy while reducing its price target to A$5.00, arguing that the sharp de-rating has created an attractive risk-reward entry point given the company’s cash position and production credentials. Canaccord maintained a Buy rating with a target of A$6.40, while Macquarie backed an Outperform view with a A$6.25 target.
The tension at the heart of the PLS Group story heading into Q4 is a familiar one in commodity stocks where you see a disconnect between near-term price dynamics and longer-term fundamental value. The quarterly pattern over the past year offers some historical context, though it should be treated with caution.
PLS Group enters Q4 2026 as a stock caught between record operational performance and a commodity price cycle that has turned against it in the short term, with the P2000 feasibility study and the trajectory of lithium spot prices likely to serve as the two most important catalysts for determining what happens in the final quarter.
